Treatment of Intractable Pruritus in Drug Induced Cholestasis with Albumin Dialysis: A Report of Two Cases
暂无分享,去创建一个
H. Schwaighofer | C. Feistritzer | M. Joannidis | H. Zoller | C. Wiedermann | I. Graziadei | A. Propst | R. Bellmann
[1] H. Schwaighofer,et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] I. Marino,et al. Effect of molecular adsorbent recirculating system in hepatitis C virus‐related intractable pruritus , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] U. Beuers,et al. Extrahepatic manifestations of cholestasis , 2002, Journal of gastroenterology and hepatology.
[4] E. Ben-Chetrit,et al. Paroxetine Associated Hepatotoxicity: A Report of 3 Cases and a Review of the Literature , 2002, Pharmacopsychiatry.
[5] A. Hofmann. Cholestatic liver disease: pathophysiology and therapeutic options. , 2002, Liver.
[6] C. Franssen,et al. Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). , 2002, Liver.
[7] P. Berloco,et al. Use of MARS in the Treatment of Acute Liver Failure: Preliminary Monocentric Experience , 2001 .
[8] R. Cortesini,et al. Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. , 2001, Transplantation proceedings.
[9] C. Sempoux,et al. Drug and toxin‐induced bile duct disorders , 2000, Journal of gastroenterology and hepatology.
[10] M. Löhr,et al. Liver support by extracorporeal blood purification: A clinical observation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] C. Ghent. The pruritus of cholestasis , 1999, Hepatology.
[12] M. Löhr,et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. , 1999, Artificial organs.
[13] G. Gores,et al. Cholestasis confers resistance to the rat liver mitochondrial permeability transition. , 1998, Gastroenterology.
[14] E. Gabazza,et al. Polyethylene glycol-modified bilirubin oxidase improves hepatic energy charge and urinary prostaglandin levels in rats with obstructive jaundice. , 1998, Journal of hepatology.
[15] N. Bergasa,et al. Why do cholestatic patients itch? , 1996, Gut.
[16] R. Melchert,et al. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. , 1995, Journal of pharmacological and toxicological methods.
[17] D. Alling,et al. Effects of Naloxone Infusions in Patients with the Pruritus of Cholestasis: A Double-Blind, Randomized, Controlled Trial , 1995, Annals of Internal Medicine.
[18] J. Ostrow,et al. Pruritus in hepatic cholestasis. Pathogenesis and therapy. , 1985, Archives of dermatology.
[19] Roger Williams,et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. , 2003, Journal of hepatology.
[20] J. George,et al. Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs , 2002, Seminars in liver disease.
[21] J. Boyer,et al. Mechanisms of Hepatic Transport of Drugs: Implications for Cholestatic Drug Reactions , 2002, Seminars in liver disease.
[22] G. Gores,et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.
[23] N. Kawada,et al. [Drug-induced cholestasis]. , 1995, Ryoikibetsu shokogun shirizu.